KEGG   DISEASE: パーキンソン病
エントリ  
H00057                                                             
名称    
パーキンソン病
概要    
Parkinson disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Both environmental factors and mutations in familial PD-linked genes such as SNCA, Parkin, DJ-1, PINK1 and LRRK2 are associated with PD pathogenesis. These pathogenic mutations and environmental factors are known to cause disease due to oxidative stress, intracellular Ca2+ homeostasis impairment, mitochondrial dysfunctions and altered protein handling compromising key roles of DA neuronal function and survival. The demise of DA neurons located in the SNc leads to a drop in the dopaminergic input to the striatum, which is hypothesized to impede movement by inducing hypo and hyper activity in striatal spiny projection neurons (SPNs) of the direct (dSPNs) and indirect (iSPNs) pathways in the basal ganglia, respectively.
カテゴリ  
神経変性疾患
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 08 神経系の疾患
  運動障害
   8A00  パーキンソン症候群
    H00057  パーキンソン病
パスウェイに基づく疾患分類 [BR:jp08402]
 アミノ酸代謝
  nt06028  ドパミンとセロトニンの代謝
   H00057  パーキンソン病
 細胞プロセス
  nt06534  小胞体ストレス応答
   H00057  パーキンソン病
  nt06536  マイトファジー
   H00057  パーキンソン病
  nt06535  エフェロサイトーシス
   H00057  パーキンソン病
指定難病 [jp08407.html]
 H00057
疾患パスウェイ
hsa05012  パーキンソン病
パスウェイ 
hsa04137  Mitophagy - animal
ネットワーク
nt06028 Dopamine and serotonin metabolism
nt06463 Parkinson disease
nt06466 Pathways of neurodegeneration
nt06534 Unfolded protein response
nt06535 Efferocytosis
nt06536 Mitophagy
病因遺伝子 
(PARK1/PARK4) SNCA (duplication, triplication) [HSA:6622] [KO:K04528]
(PARK2) PRKN [HSA:5071] [KO:K04556]
(PARK5) UCHL1 [HSA:7345] [KO:K05611]
(PARK6) PINK1 [HSA:65018] [KO:K05688]
(PARK7) PARK7 [HSA:11315] [KO:K05687]
(PARK8) LRRK2 [HSA:120892] [KO:K08844]
(PARK9) ATP13A2 [HSA:23400] [KO:K13526]
(PARK11) GIGYF2 [HSA:26058] [KO:K18730]
(PARK13) HTRA2 [HSA:27429] [KO:K08669]
(PARK14) PLA2G6 [HSA:8398] [KO:K16343]
(PARK15) FBXO7 [HSA:25793] [KO:K10293]
(PARK17) VPS35 [HSA:55737] [KO:K18468]
(PARK18) EIF4G1 [HSA:1981] [KO:K03260]
(PARK19) DNAJC6 [HSA:9829] [KO:K09526]
(PARK22) CHCHD2 [HSA:51142] [KO:K22758]
(PARK23) VPS13C [HSA:54832] [KO:K19525]
(PARK24) PSAP [HSA:5660] [KO:K12382]
(PARK25) PTPA [HSA:5524] [KO:K17605]
(IDLDP) NR4A2 [HSA:4929] [KO:K08558]
MAPT [HSA:4137] [KO:K04380]
治療薬   
ゾニサミド [DR:D00538]
レボドパ [DR:D00059]
ドロキシドパ [DR:D01277]
カベルゴリン [DR:D00987]
アポモルヒネ塩酸塩水和物 [DR:D02004]
レボドパ・カルビドパ水和物 [DR:D00253]
レボドパ・ベンセラジド塩酸塩 [DR:D02135]
カルビドパ・レボドパ・エンタカポン [DR:D10293]
ホスレボドパ・ホスカルビドパ水和物 [DR:D12494]
ペルゴリドメシル酸塩 [DR:D00502]
ロピニロール塩酸塩 [DR:D00784]
プラミペキソール塩酸塩水和物 [DR:D00559]
ロチゴチン [DR:D05768]
セレギリン塩酸塩 [DR:D00785]
ラサギリンメシル酸塩 [DR:D02562]
サフィナミドメシル酸塩 [DR:D10191]
エンタカポン [DR:D00781]
オピカポン [DR:D10825]
イストラデフィリン [DR:D04641]
コメント  
Disease class: synucleinopathy
Affected region: substantia nigra, putamen, caudate nucleus, hypothalamus
Microscopic lesion: Lewy bodies
リンク   
ICD-11: 8A00.0
ICD-10: G20
MeSH: D010300
OMIM: 168600 168601 605543 600116 605909 606324 607060 606693 607688 610297 612953 260300 614203 614251 615528 616710 616840 619491 620482 619911 260540
文献    
  著者
Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C
  タイトル
The genetics of Parkinson's syndromes: a critical review.
  雑誌
Curr Opin Genet Dev 19:254-65 (2009)
DOI:10.1016/j.gde.2009.03.008
文献    
PMID:17582365 (PARK2, PARK6, PARK8)
  著者
Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE
  タイトル
Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
  雑誌
Lancet Neurol 6:652-62 (2007)
DOI:10.1016/S1474-4422(07)70174-6
文献    
PMID:17499497 (PARK2, PARK6, PARK7)
  著者
Dodson MW, Guo M
  タイトル
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
  雑誌
Curr Opin Neurobiol 17:331-7 (2007)
DOI:10.1016/j.conb.2007.04.010
文献    
PMID:12953260 (PARK7)
  著者
Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW
  タイトル
The role of pathogenic DJ-1 mutations in Parkinson's disease.
  雑誌
Ann Neurol 54:283-6 (2003)
DOI:10.1002/ana.10675
文献    
PMID:19182805 (PARK9)
  著者
Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet JC, Lindquist S
  タイトル
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.
  雑誌
Nat Genet 41:308-15 (2009)
DOI:10.1038/ng.300
文献    
PMID:19297401 (PARK1-15)
  著者
Lesage S, Brice A
  タイトル
Parkinson's disease: from monogenic forms to genetic susceptibility factors.
  雑誌
Hum Mol Genet 18:R48-59 (2009)
DOI:10.1093/hmg/ddp012
文献    
PMID:27090875 (PARK17, PARK18, PARK19)
  著者
Hernandez DG, Reed X, Singleton AB
  タイトル
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.
  雑誌
J Neurochem 139 Suppl 1:59-74 (2016)
DOI:10.1111/jnc.13593
文献    
PMID:25662902 (PARK22)
  著者
Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, Li Y, Ogaki K, Ando M, Yoshino H, Tomiyama H, Nishioka K, Hasegawa K, Saiki H, Satake W, Mogushi K, Sasaki R, Kokubo Y, Kuzuhara S, Toda T, Mizuno Y, Uchiyama Y, Ohno K, Hattori N
  タイトル
CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
  雑誌
Lancet Neurol 14:274-82 (2015)
DOI:10.1016/S1474-4422(14)70266-2
文献    
PMID:26942284 (PARK23)
  著者
Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, Cormier-Dequaire F, Hassoun SM, Pujol C, Ciura S, Erpapazoglou Z, Usenko T, Maurage CA, Sahbatou M, Liebau S, Ding J, Bilgic B, Emre M, Erginel-Unaltuna N, Guven G, Tison F, Tranchant C, Vidailhet M, Corvol JC, Krack P, Leutenegger AL, Nalls MA, Hernandez DG, Heutink P, Gibbs JR, Hardy J, Wood NW, Gasser T, Durr A, Deleuze JF, Tazir M, Destee A, Lohmann E, Kabashi E, Singleton A, Corti O, Brice A
  タイトル
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.
  雑誌
Am J Hum Genet 98:500-13 (2016)
DOI:10.1016/j.ajhg.2016.01.014
文献    
PMID:32201884 (PARK24)
  著者
Oji Y, Hatano T, Ueno SI, Funayama M, Ishikawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N
  タイトル
Variants in saposin D domain of prosaposin gene linked to Parkinson's disease.
  雑誌
Brain 143:1190-1205 (2020)
DOI:10.1093/brain/awaa064
文献    
PMID:36073231 (PARK25)
  著者
Fevga C, Tesson C, Carreras Mascaro A, Courtin T, van Coller R, Sakka S, Ferraro F, Farhat N, Bardien S, Damak M, Carr J, Ferrien M, Boumeester V, Hundscheid J, Grillenzoni N, Kessissoglou IA, Kuipers DJS, Quadri M, Corvol JC, Mhiri C, Hassan BA, Breedveld GJ, Lesage S, Mandemakers W, Brice A, Bonifati V
  タイトル
PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability.
  雑誌
Brain 146:1496-1510 (2023)
DOI:10.1093/brain/awac326
文献    
PMID:31428396 (IDLDP)
  著者
Ramos LLP, Monteiro FP, Sampaio LPB, Costa LA, Ribeiro MDO, Freitas EL, Kitajima JP, Kok F
  タイトル
Heterozygous loss of function of NR4A2 is associated with intellectual deficiency, rolandic epilepsy, and language impairment.
  雑誌
Clin Case Rep 7:1582-1584 (2019)
DOI:10.1002/ccr3.2260
文献    
PMID:11220749 (MAPT)
  著者
Pastor P, Pastor E, Carnero C, Vela R, Garcia T, Amer G, Tolosa E, Oliva R
  タイトル
Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.
  雑誌
LinkDB    

» English version

DBGET integrated database retrieval system